Inhibition of tumor cell migration and metastasis by the proton-sensing GPR4 receptor

Cancer Letters

Volumn 312, Issue 2, 2011, Pages 197-208

  Castellone, Reid D ^a,b   Leffler, Nancy R ^a   Dong, Lixue ^a   Yang, Li V ^a,c  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Acidosis; Cancer metastasis; Cell migration; GPR4; Tumor microenvironment

Indexed keywords

CALPEPTIN; CN 01; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 4; MATRIGEL; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ACIDITY; ACIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL PH; CONTROLLED STUDY; FEMALE; GENETIC ENGINEERING; IN VIVO STUDY; LUNG METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS INHIBITION; MIGRATION INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR UPREGULATION; STRESS FIBER; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; MICE; NEOPLASM METASTASIS; NIH 3T3 CELLS; POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED;

MUS;

EID: 80053945028     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.08.013     Document Type: Article

References (54)

1. Fidler I.J. Critical determinants of metastasis. Semin. Cancer Biol. 2002, 12:89-96.
2. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006, 12:895-904.
3. Cairns R., Papandreou I., Denko N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol. Cancer Res. 2006, 4:61-70.
4. Fukumura D., Jain R.K. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc. Res. 2007, 74:72-84.
5. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
6. Buerkle A., Weber W.A. Imaging of tumor glucose utilization with positron emission tomography. Cancer Metastasis Rev. 2008, 27:545-554.
7. Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature 2005, 438:967-974.
8. Jacoby E., Bouhelal R., Gerspacher M., Seuwen K. The 7 TM G-protein-coupled receptor target family. ChemMedChem 2006, 1:761-782.
9. Lundstrom K. Latest development in drug discovery on G protein-coupled receptors. Curr. Protein Pept. Sci. 2006, 7:465-470.
10. Lappano R., Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov. 2011, 10:47-60.
11. Sanchez T., Thangada S., Wu M.T., Kontos C.D., Wu D., Wu H., Hla T. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc. Natl. Acad. Sci. USA 2005, 102:4312-4317.
12. Ludwig M.G., Vanek M., Guerini D., Gasser J.A., Jones C.E., Junker U., Hofstetter H., Wolf R.M., Seuwen K. Proton-sensing G-protein-coupled receptors. Nature 2003, 425:93-98.
13. Radu C.G., Nijagal A., McLaughlin J., Wang L., Witte O.N. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc. Natl. Acad. Sci. USA 2005, 102:1632-1637.
14. Yang L.V., Radu C.G., Roy M., Lee S., McLaughlin J., Teitell M.A., Iruela-Arispe M.L., Witte O.N. Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor. Mol. Cell. Biol. 2007, 27:1334-1347.
15. Liu J.P., Nakakura T., Tomura H., Tobo M., Mogi C., Wang J.Q., He X.D., Takano M., Damirin A., Komachi M., Sato K., Okajima F. Each one of certain histidine residues in G-protein-coupled receptor GPR4 is critical for extracellular proton-induced stimulation of multiple G-protein-signaling pathways. Pharmacol. Res. 2010, 61:499-505.
16. Sin W.C., Zhang Y., Zhong W., Adhikarakunnathu S., Powers S., Hoey T., An S., Yang J. G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers. Oncogene 2004, 23:6299-6303.
17. Yang L.V., Radu C.G., Wang L., Riedinger M., Witte O.N. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood 2005, 105:1127-1134.
18. Albini A. Tumor and endothelial cell invasion of basement membranes. The Matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol. Oncol. Res. 1998, 4:230-241.
19. Overwijk W.W., Restifo N.P. B16 as a mouse model for human melanoma. Curr. Protoc. Immunol. Chapter 2001, 20. Unit 20.1.
20. Tobo M., Tomura H., Mogi C., Wang J.Q., Liu J.P., Komachi M., Damirin A., Kimura T., Murata N., Kurose H., Sato K., Okajima F. Previously postulated " ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms. Cell. Signal. 2007, 19:1745-1753.
21. Schoenwaelder S.M., Burridge K. Evidence for a calpeptin-sensitive protein-tyrosine phosphatase upstream of the small GTPase Rho. A novel role for the calpain inhibitor calpeptin in the inhibition of protein-tyrosine phosphatases. J. Biol. Chem. 1999, 274:14359-14367.
22. Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev. 2009, 28:5-14.
23. Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2:133-142.
24. Rodriguez L.G., Wu X., Guan J.L. Wound-healing assay. Methods Mol. Biol. 2005, 294:23-29.
25. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
26. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
27. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
28. Helmlinger G., Sckell A., Dellian M., Forbes N.S., Jain R.K. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin. Cancer Res. 2002, 8:1284-1291.
29. Yamagata M., Hasuda K., Stamato T., Tannock I.F. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br. J. Cancer 1998, 77:1726-1731.
30. Effros R.M., Chinard F.P. The in vivo pH of the extravascular space of the lung. J. Clin. Invest. 1969, 48:1983-1996.
31. Nielson D.W., Goerke J., Clements J.A. Alveolar subphase pH in the lungs of anesthetized rabbits. Proc. Natl. Acad. Sci. USA 1981, 78:7119-7123.
32. Voeks D.J., Martiniello-Wilks R., Russell P.J. Derivation of MPR and TRAMP models of prostate cancer and prostate cancer metastasis for evaluation of therapeutic strategies. Urol. Oncol. 2002, 7:111-118.
33. Singh L.S., Berk M., Oates R., Zhao Z., Tan H., Jiang Y., Zhou A., Kirmani K., Steinmetz R., Lindner D., Xu Y. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. J. Natl. Cancer Inst. 2007, 99:1313-1327.
34. Xu Y., Zhu K., Hong G., Wu W., Baudhuin L.M., Xiao Y., Damron D.S. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat. Cell Biol. 2000, 2:261-267. (Retraction, 8:299, 2006).
35. Zhu K., Baudhuin L.M., Hong G., Williams F.S., Cristina K.L., Kabarowski J.H., Witte O.N., Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 2001, 276:41325-41335. (Retraction, 280:43280, 2005).
36. Frick K.K., Krieger N.S., Nehrke K., Bushinsky D.A. Metabolic acidosis increases intracellular calcium in bone cells through activation of the proton receptor OGR1. J. Bone Miner. Res. 2009, 24:305-313.
37. Ichimonji I., Tomura H., Mogi C., Sato K., Aoki H., Hisada T., Dobashi K., Ishizuka T., Mori M., Okajima F. Extracellular acidification stimulates IL-6 production and Ca(2+) mobilization through proton-sensing OGR1 receptors in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:L567-L577.
38. Pereverzev A., Komarova S.V., Korcok J., Armstrong S., Tremblay G.B., Dixon S.J., Sims S.M. Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. Bone 2008, 42:150-161.
39. Sun X., Yang L.V., Tiegs B.C., Arend L.J., McGraw D.W., Penn R.B., Petrovic S. Deletion of the pH sensor GPR4 decreases renal acid excretion. J. Am. Soc. Nephrol. 2010, 21:1745-1755.
40. Tomura H., Wang J.Q., Komachi M., Damirin A., Mogi C., Tobo M., Kon J., Misawa N., Sato K., Okajima F. Prostaglandin I(2) production and cAMP accumulation in response to acidic extracellular pH through OGR1 in human aortic smooth muscle cells. J. Biol. Chem. 2005, 280:34458-34464.
41. Kienast Y., von Baumgarten L., Fuhrmann M., Klinkert W.E., Goldbrunner R., Herms J., Winkler F. Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 2010, 16:116-122.
42. Li Z., Chang Z., Chiao L.J., Kang Y., Xia Q., Zhu C., Fleming J.B., Evans D.B., Chiao P.J. TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation. Cancer Res. 2009, 69:7851-7859.
43. Ying H., Biroc S.L., Li W.W., Alicke B., Xuan J.A., Pagila R., Ohashi Y., Okada T., Kamata Y., Dinter H. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol. Cancer Ther. 2006, 5:2158-2164.
44. Vial E., Sahai E., Marshall C.J. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4:67-79.
45. Takashima S., Sugimoto N., Takuwa N., Okamoto Y., Yoshioka K., Takamura M., Takata S., Kaneko S., Takuwa Y. G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. Cardiovasc. Res. 2008, 79:689-697.
46. Navenot J.M., Fujii N., Peiper S.C. Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis. Mol. Pharmacol. 2009, 75:1300-1306.
47. Iguchi T., Sakata K., Yoshizaki K., Tago K., Mizuno N., Itoh H. Orphan G proteincoupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway. J. Biol. Chem. 2008, 283:14469-14478.
48. Xu L., Begum S., Hearn J.D., Hynes R.O. GPR56, an atypical G protein-coupled receptor* binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 2006, 103:9023-9028.
49. Cox E.A., Sastry S.K., Huttenlocher A. Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases. Mol. Biol. Cell 2001, 12:265-277.
50. Gatenby R.A., Gawlinski E.T., Gmitro A.F., Kaylor B., Gillies R.J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 2006, 66:5216-5223.
51. Chen J.L., Lucas J.E., Schroeder T., Mori S., Wu J., Nevins J., Dewhirst M., West M., Chi J.T. The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet. 2008, 4:e1000293.
52. Ihara Y., Kihara Y., Hamano F., Yanagida K., Morishita Y., Kunita A., Yamori T., Fukayama M., Aburatani H., Shimizu T., Ishii S. The G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) facilitates tumor development by serving as an extracellular pH sensor. Proc. Natl. Acad. Sci. USA 2010, 107:17309-17314.
53. Taketo M.M. Reflections on the spread of metastasis to cancer prevention. Cancer Prev. Res. (Phila) 2011, 4:324-328.
54. The Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615.